Cargando…

New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study

SIMPLE SUMMARY: In children undergoing allogenic HCT, invasive fungal infections are a significant cause of mortality, for which ECIL-8 have proposed systematic primary prophylaxis. This study evaluates our local strategy of not systematizing it, and reveals a similar IFI incidence and mortality rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricard, Noémi, Zebali, Lelia, Renard, Cécile, Goutagny, Marie-Pierre, Benezech, Sarah, Bertrand, Yves, Philippe, Michael, Domenech, Carine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093632/
https://www.ncbi.nlm.nih.gov/pubmed/37046769
http://dx.doi.org/10.3390/cancers15072107
_version_ 1785023633020682240
author Ricard, Noémi
Zebali, Lelia
Renard, Cécile
Goutagny, Marie-Pierre
Benezech, Sarah
Bertrand, Yves
Philippe, Michael
Domenech, Carine
author_facet Ricard, Noémi
Zebali, Lelia
Renard, Cécile
Goutagny, Marie-Pierre
Benezech, Sarah
Bertrand, Yves
Philippe, Michael
Domenech, Carine
author_sort Ricard, Noémi
collection PubMed
description SIMPLE SUMMARY: In children undergoing allogenic HCT, invasive fungal infections are a significant cause of mortality, for which ECIL-8 have proposed systematic primary prophylaxis. This study evaluates our local strategy of not systematizing it, and reveals a similar IFI incidence and mortality rate. ABSTRACT: Background: Allogenic hematopoietic stem cell transplantation (a-HCT) remains a therapeutic treatment for many pediatric hematological diseases. The occurrence of invasive fungal infections (IFIs) is a complication for which ECIL-8 recommends primary antifungal prophylaxis. In this study, we evaluated the impact of our local strategy of not systematically administering primary antifungal prophylaxis in children undergoing a-HCT on the occurrence and mortality of IFIs. Methods: We performed a retrospective monocentric study from 2010 to 2020. We retained all proven and probable IFIs diagnosed during the first year post a-HCT. Results: 308 patients were included. Eighteen patients developed twenty IFIs (thirteen proven, seven probable) (6.5%) among which aspergillosis (n = 10, 50%) and candidosis (n = 7, 35%) were the most frequently diagnosed infections. Only 2% of children died because of an IFI, which represents 14% of all deaths. Multivariate analysis found that age > 10 years (OR: 0.29), the use of a therapeutic antiviral treatment (OR: 2.71) and a low neutrophil count reconstitution (OR: 0.93) were significantly associated with the risk of IFI occurrence. There was also a trend of malignant underlying disease and status ≥ CR2 but it was not retained in multivariate analysis. Conclusions: IFI occurrence was not higher in our cohort than what is reported in the literature with the use of systematic antifungal prophylaxis, with a good survival rate nonetheless. Thus, a prophylaxis could be considered for children with a high risk of IFI such as those aged over 10 years.
format Online
Article
Text
id pubmed-10093632
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100936322023-04-13 New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study Ricard, Noémi Zebali, Lelia Renard, Cécile Goutagny, Marie-Pierre Benezech, Sarah Bertrand, Yves Philippe, Michael Domenech, Carine Cancers (Basel) Article SIMPLE SUMMARY: In children undergoing allogenic HCT, invasive fungal infections are a significant cause of mortality, for which ECIL-8 have proposed systematic primary prophylaxis. This study evaluates our local strategy of not systematizing it, and reveals a similar IFI incidence and mortality rate. ABSTRACT: Background: Allogenic hematopoietic stem cell transplantation (a-HCT) remains a therapeutic treatment for many pediatric hematological diseases. The occurrence of invasive fungal infections (IFIs) is a complication for which ECIL-8 recommends primary antifungal prophylaxis. In this study, we evaluated the impact of our local strategy of not systematically administering primary antifungal prophylaxis in children undergoing a-HCT on the occurrence and mortality of IFIs. Methods: We performed a retrospective monocentric study from 2010 to 2020. We retained all proven and probable IFIs diagnosed during the first year post a-HCT. Results: 308 patients were included. Eighteen patients developed twenty IFIs (thirteen proven, seven probable) (6.5%) among which aspergillosis (n = 10, 50%) and candidosis (n = 7, 35%) were the most frequently diagnosed infections. Only 2% of children died because of an IFI, which represents 14% of all deaths. Multivariate analysis found that age > 10 years (OR: 0.29), the use of a therapeutic antiviral treatment (OR: 2.71) and a low neutrophil count reconstitution (OR: 0.93) were significantly associated with the risk of IFI occurrence. There was also a trend of malignant underlying disease and status ≥ CR2 but it was not retained in multivariate analysis. Conclusions: IFI occurrence was not higher in our cohort than what is reported in the literature with the use of systematic antifungal prophylaxis, with a good survival rate nonetheless. Thus, a prophylaxis could be considered for children with a high risk of IFI such as those aged over 10 years. MDPI 2023-03-31 /pmc/articles/PMC10093632/ /pubmed/37046769 http://dx.doi.org/10.3390/cancers15072107 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ricard, Noémi
Zebali, Lelia
Renard, Cécile
Goutagny, Marie-Pierre
Benezech, Sarah
Bertrand, Yves
Philippe, Michael
Domenech, Carine
New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study
title New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study
title_full New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study
title_fullStr New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study
title_full_unstemmed New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study
title_short New Perspectives on Primary Prophylaxis of Invasive Fungal Infection in Children Undergoing Hematopoietic Stem Cell Transplantation: A 10-Year Retrospective Cohort Study
title_sort new perspectives on primary prophylaxis of invasive fungal infection in children undergoing hematopoietic stem cell transplantation: a 10-year retrospective cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093632/
https://www.ncbi.nlm.nih.gov/pubmed/37046769
http://dx.doi.org/10.3390/cancers15072107
work_keys_str_mv AT ricardnoemi newperspectivesonprimaryprophylaxisofinvasivefungalinfectioninchildrenundergoinghematopoieticstemcelltransplantationa10yearretrospectivecohortstudy
AT zebalilelia newperspectivesonprimaryprophylaxisofinvasivefungalinfectioninchildrenundergoinghematopoieticstemcelltransplantationa10yearretrospectivecohortstudy
AT renardcecile newperspectivesonprimaryprophylaxisofinvasivefungalinfectioninchildrenundergoinghematopoieticstemcelltransplantationa10yearretrospectivecohortstudy
AT goutagnymariepierre newperspectivesonprimaryprophylaxisofinvasivefungalinfectioninchildrenundergoinghematopoieticstemcelltransplantationa10yearretrospectivecohortstudy
AT benezechsarah newperspectivesonprimaryprophylaxisofinvasivefungalinfectioninchildrenundergoinghematopoieticstemcelltransplantationa10yearretrospectivecohortstudy
AT bertrandyves newperspectivesonprimaryprophylaxisofinvasivefungalinfectioninchildrenundergoinghematopoieticstemcelltransplantationa10yearretrospectivecohortstudy
AT philippemichael newperspectivesonprimaryprophylaxisofinvasivefungalinfectioninchildrenundergoinghematopoieticstemcelltransplantationa10yearretrospectivecohortstudy
AT domenechcarine newperspectivesonprimaryprophylaxisofinvasivefungalinfectioninchildrenundergoinghematopoieticstemcelltransplantationa10yearretrospectivecohortstudy